Akèy › Kansè tete negatif triple › Lwizyàn › New Orleans
Etid klinik pou Kansè tete negatif triple nan New Orleans, LA
3 etid pou Kansè tete negatif triple ap chèche patisipan nan sit nan ak bò kote New Orleans (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Ap rekriteFaz 3
- Ochsner Clinic Foundation ( Site 0021), New Orleans
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
Ap rekriteFaz 3
- University Medical Center - New Orleans, New Orleans
CtDNA Based MRD Testing for NAC Monitoring in TNBC
Ap rekriteEtid obsèvasyon
- Louisiana State University, New Orleans
Etid Kansè tete negatif triple nan lòt vil
- Houston, TX42 etid
- New York City, NY31 etid
- Nashville, TN28 etid
- Los Angeles, CA27 etid
- Boston, MA26 etid
- San Antonio, TX23 etid
- St. Louis, MO21 etid
- Arlington, VA20 etid
- Atlanta, GA20 etid
- Dallas, TX18 etid
- Chicago, IL16 etid
- Columbus, OH16 etid
Lòt etid nan New Orleans
- Kansè (tout kalite)12 etid
- Kansè ovè12 etid
- Kansè nan tete11 etid
- Kansè pwostat10 etid
- Kansè Endomèt9 etid
- Kansè Metastatik9 etid
- Kansè poumon9 etid
- Kansè Poumon ki pa ti selil9 etid
- Maladi kadyovaskilè9 etid
- Obèsite8 etid
- Maladi fwa steatotik8 etid
- Kansè kolorektal8 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.